Are we adequately prepared to handle the anticipated 3rd peak of COVID-19: A KAP survey among HCWs


Submitted: 24 November 2021
Accepted: 22 February 2022
Published: 17 March 2022
Abstract Views: 1304
PDF: 202
HTML: 23
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Narendra Pal Singh Department of Microbiology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India.
  • Nisha Goyal Department of Microbiology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India.
  • Vikas Saini Department of Microbiology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India.
  • Abhilasha Kapoor Department of Community Medicine, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India.
  • Seema Gangar Department of Microbiology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India.

Experts in the field are predicting a third COVID-19 peak very soon in coming times, it is important to assess recent knowledge, attitude in view of prolonged exhaustion and adherence to preventive practices of HCWs. This cross-sectional study involved 168 HCWs (42 doctors, 42 nurses, 42 paramedical staff and 42 ANMs). Data was collected through online survey tool Google forms in July and August 2021. First section included sociodemographic information and infection with SARS-CoV- 2, section 2 assessed recent knowledge, section 3 practices of COVID-19 appropriate behavior and section 4 assessed attitude of HCWs. Shapiro Wilk test was used to determine normality of distribution of variables. Kruskal-Wallis and Mann-Whitney U tests were used to determine the association between two variables. Pairwise comparison was done following a significant Kruskal-Wallis test using Bonferroni’s correction. 42.9% of the HCWs and family members of 44.6% HCWs were infected with SARS-CoV-2. 54.1% of infected HCWs were infected during the March- May 2021 peak. 85.1% HCWs had taken COVID-19 vaccine. Mean knowledge, attitude, practice scores were 7.88±3.03(maximum score: 12), 20.35±3.2 (maximum score: 25), 69.89±9.39 (maximum score: 85) respectively. Only 48.8% HCWs had good knowledge about more recent COVID-19 information. A significant association was observed between profession and knowledge scores (p<0.001). Over 85% HCWs had good scores for attitude towards COVID-19 and 88.7% HCWs scored good in COVID-19 appropriate behavior practices. Our HCWs need to be better equipped with the more recently available knowledge about COVID-19 to improve our preparedness for the next anticipated peak.


Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395:470-3.

World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Accessed on: 17.09.2021. Available from: https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)

Khan W, Shrungaram RV, Broor S, Parveen S. Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells. Europ Resp J 2015;46:PA2673.

Haider MS, Khan WH, Deeba F, et al. BA9 lineage of respiratory syncytial virus from across the globe and its evolutionary dynamics. PloS One 2018;13:e0193525.

Duchene S, Featherstone L, Haritopoulou-Sinanidou M, et al. Temporal signal and the phylodynamic threshold of SARS-CoV-2. Virus Evol 2020;6:veaa061.

Davidson AD, Williamson MK, Lewis S, et al. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein. Genome Med 2020;12:1-5.

World Health Organization. Tracking SARS-CoV-2 variants. 2021. Accessed:20.07.2021. Available from: https://www.who. int/en/activities/tracking-SARS-CoV-2-variants/

Toyoshima Y, Nemoto K, Matsumoto S, et al. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Human Gen 2020;65:1075-82.

A global initiative on sharing avian flu data (GISAID). hCoV-19 tracking of variants (see menu option GR/501Y.V3(P.1). Accessed:20.07.2021. Available from: https://www.gisaid.org/hcov19-variants/

Public Health England (PHE). SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 14. London: PHS. Accessed: 03.06.2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/991343/Variants_of_Concern_VOC_Technical_Briefing_14.pdf

Challen R, Dyson L, Overton CE, et al. Early epidemiological signatures of novel SARS-CoV-2 variants: establishment of B. 1.617. 2 in England. medRxiv 2021.

Yang W, Shaman J. COVID-19 pandemic dynamics in India and impact of the SARS-CoV-2 Delta (B. 1.617. 2) variant. medRxiv 2021.

Voysey M, Clemens SA, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021;397:99-111.

Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England J Med 2021;384:403-16.

Levine-Tiefenbrun M, Yelin I, Katz R, et al. Decreased SARS-CoV-2 viral load following vaccination. Nature Medicine. Nat Med 2021;27:790–792.

Zeyaullah M, AlShahrani AM, Muzammil K, et al. COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern. Front Gen 2021;12.

Verma SK, Chandan N, Narayanmurthy MR. Knowledge, attitude, and practices towards COVID-19 among ayurvedic practitioners of Karnataka, India: a cross-sectional survey. Int J Community Med Public Health 2020;7:4056-62.

Verma SK, Kumar DS, Khanum RS, et al. Knowledge, attitude and practices towards COVID-19 among healthcare workers of Karnataka, India: a cross-sectional survey. Int J Community Med Public Health 2020;7:4889-94.

Al Maskari Z, Al Blushi A, Khamis F, et al. Characteristics of healthcare workers infected with COVID-19: A cross-sectional observational study. Int J Infect Dis 2021;102:32-36.

Mehta K, Dhaliwal BK, Zodpey S, et al. COVID-19 vaccine acceptance among healthcare workers in India: Results from a cross-sectional survey. medRxiv 2021.

Almohammed OA, Aldwihi LA, Alragas AM, et al. Knowledge, attitude, and practices associated with COVID-19 among healthcare workers in hospitals: a cross-sectional study in Saudi Arabia. Front Public Health 2021;9:643053.

Kamacooko O, Kitonsa J, Bahemuka UM, et al. Knowledge, attitudes, and practices regarding COVID-19 among healthcare workers in Uganda: a cross-sectional survey. Int J Environ Res Public Health 2021;18:7004.

Goyal N, Loomba P, Sharma A, et al. Are we growing tired of being cautious in this apparently endless COVID-19 pandemic: A KAP study in HCWs of a tertiary care center to determine the answer. Indian J Health Sci Care 2021;8:19-28.

Singh, N. P., Goyal, N., Saini, V., Kapoor, A. ., & Gangar, S. (2022). Are we adequately prepared to handle the anticipated 3rd peak of COVID-19: A KAP survey among HCWs. Healthcare in Low-Resource Settings, 10(1). https://doi.org/10.4081/hls.2022.10298

Downloads

Download data is not yet available.

Citations